Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Breast Cancer AJCC v6 and v7”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03101748
What this trial is testing

Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer

Who this might be right for
Breast Inflammatory CarcinomaLocally Advanced Breast CarcinomaMetastatic Breast Carcinoma+5 more
M.D. Anderson Cancer Center 34
Large-scale testing (Phase 3)Study completedNCT02003209
What this trial is testing

Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer

Who this might be right for
HER2-Positive Breast CarcinomaHormone Receptor-Positive Breast CarcinomaStage IB Breast Cancer AJCC v7+5 more
National Cancer Institute (NCI) 315
Testing effectiveness (Phase 2)WithdrawnNCT03326258
What this trial is testing

Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmEstrogen Receptor NegativeGPNMB Positive+15 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT02713269
What this trial is testing

Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord

Who this might be right for
Malignant Digestive System NeoplasmMetastatic Head and Neck CarcinomaMetastatic Kidney Carcinoma+10 more
M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)Ended earlyNCT02658812
What this trial is testing

Talimogene Laherparepvec in Treating Patients With Recurrent Breast Cancer That Cannot Be Removed by Surgery

Who this might be right for
Malignant Chest Wall NeoplasmRecurrent Breast CarcinomaRecurrent Inflammatory Breast Carcinoma+2 more
M.D. Anderson Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT00684983
What this trial is testing

Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer

Who this might be right for
HER2 Positive Breast CarcinomaRecurrent Breast CarcinomaStage IIIB Breast Cancer AJCC v7+2 more
National Cancer Institute (NCI) 64
Testing effectiveness (Phase 2)Study completedNCT00861705
What this trial is testing

Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery

Who this might be right for
Male Breast CarcinomaStage IIA Breast Cancer AJCC v6 and v7Stage IIB Breast Cancer AJCC v6 and v7+2 more
National Cancer Institute (NCI) 454
Testing effectiveness (Phase 2)Study completedNCT02654119
What this trial is testing

Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Stage I-II HER2/Neu Positive Breast Cancer After Surgery

Who this might be right for
HER2 Positive Breast CarcinomaStage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7+4 more
University of Nebraska 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT02778685
What this trial is testing

Pembrolizumab, Endocrine Therapy, and Palbociclib in Treating Postmenopausal Patients With Newly Diagnosed Metastatic Stage IV Estrogen Receptor Positive Breast Cancer

Who this might be right for
Metastatic Breast CarcinomaStage IV Breast Cancer AJCC v6 and v7
City of Hope Medical Center 47
Testing effectiveness (Phase 2)Active Not RecruitingNCT02912312
What this trial is testing

Hypofractionated vs. Conventional Regional Nodal Radiation Therapy for Patients With Invasive Breast Cancer

Who this might be right for
Invasive Breast CarcinomaStage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7+6 more
M.D. Anderson Cancer Center 805
Testing effectiveness (Phase 2)Study completedNCT02673398
What this trial is testing

Neratinib in Treating Older Patients With Stage IV HER2-Positive Breast Cancer

Who this might be right for
HER2 Positive Breast CarcinomaStage IV Breast Cancer AJCC v6 and v7
City of Hope Medical Center 25
Testing effectiveness (Phase 2)Study completedNCT00699491
What this trial is testing

Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

Who this might be right for
Male Breast CarcinomaRecurrent Breast CarcinomaStage IV Breast Cancer AJCC v6 and v7
National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Study completedNCT03454529
What this trial is testing

The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast Cancer

Who this might be right for
Invasive Breast CarcinomaStage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7+4 more
Michael Simon 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT02754752
What this trial is testing

Electroacupuncture Therapy in Reducing Chronic Pain in Patients After Breast Cancer Treatment

Who this might be right for
Stage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7Stage IB Breast Cancer AJCC v7+7 more
M.D. Anderson Cancer Center 111
Large-scale testing (Phase 3)Study completedNCT00770809
What this trial is testing

Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery

Who this might be right for
Male Breast CarcinomaStage IIA Breast Cancer AJCC v6 and v7Stage IIB Breast Cancer AJCC v6 and v7+3 more
National Cancer Institute (NCI) 305
Testing effectiveness (Phase 2)Study completedNCT03633331
What this trial is testing

Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerHER2/Neu NegativeStage IV Breast Cancer AJCC v6 and v7
Alliance for Clinical Trials in Oncology 93
Large-scale testing (Phase 3)Active Not RecruitingNCT02750826
What this trial is testing

Breast Cancer WEight Loss Study (BWEL Study)

Who this might be right for
Breast Ductal Carcinoma In SituInvasive Breast CarcinomaStage II Breast Cancer AJCC v6 and v7+4 more
Alliance for Clinical Trials in Oncology 3,177
Large-scale testing (Phase 3)Active Not RecruitingNCT02954874
What this trial is testing

Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

Who this might be right for
Breast Carcinoma In SituInvasive Breast CarcinomaStage I Breast Cancer AJCC v7+3 more
National Cancer Institute (NCI) 1,195
Testing effectiveness (Phase 2)Active Not RecruitingNCT03012100
What this trial is testing

Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer

Who this might be right for
Bilateral Breast CarcinomaBreast Inflammatory CarcinomaStage IB Breast Cancer AJCC v7+9 more
Academic and Community Cancer Research United 280
Not applicableStudy completedNCT03568526
What this trial is testing

Sensorimotor Rehabilitation Program in Improving Quality of Life in Patients With Early Stage Breast Cancer

Who this might be right for
Peripheral NeuropathyStage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7+4 more
Ohio State University Comprehensive Cancer Center 36
Next Page